In a prospective, double-blind, randomized, placebo-controlled trial, supplementation with a combination of conventional and gut-targeted nicotinamide was safe and effective in ameliorating COVID-19 symptoms.
- Stefan Schreiber
- Georg H. Waetzig
- Philip Rosenstiel